W B Shingleton1, P E Sewell. 1. Division of Urology and Department of Radiology, University of Mississippi Medical Center, Jackson, Mississippi 39216, USA. wshingleton@surgery.umsmed.edu
Abstract
OBJECTIVE: To investigate the use of cryoablation for small renal tumours (</= 5 cm) in patients with solitary kidneys, as the advantage of this technique might be to preserve nephrons for maintaining renal function with minimal morbidity. PATIENTS AND METHODS: Patients with a radiographically documented solid renal mass in a solitary kidney were evaluated for treatment with percutaneous cryoablation. Under general anaesthesia the patients were placed in an interventional magnetic resonance imaging (MRI) unit. A gradient imaging technique was used to locate the tumour and one to four 3-mm cryoprobes placed percutaneously into the tumour. An argon-based cryoablation system was used to treat the tumour with three freeze-thaw cycles, at a probe tip temperature of -120 degrees C. Patients were admitted for 23 h observation and assessed for follow-up at 1 week, 1, 3 and 6 months, and then every 6 months. Radiological imaging studies (computed tomography or MRI) were used at 1, 3 and 6 months and every 6 months afterward, to assess for recurrent or new tumour appearance. RESULTS: To date, 14 patients with renal masses in a solitary kidney have been treated; two were lost to follow-up and excluded from the analysis, leaving 10 men and two women (mean age 62.5 years, range 29-76). In all, 15 tumours (mean diameter 3.1 cm) were treated; the mean (range) treatment time was 96.7 (30-143) min. There were no complications during treatment. Two patients had gross haematuria afterward that resolved within 24 h. The mean follow-up was 17 (2-30) months, with three patients requiring re-treatment for incomplete tumour ablation. There is no radiographic evidence of local tumour recurrence to date. In two patients the tumour was not completely ablated. There was no significant change in serum creatinine from preoperative values. CONCLUSION: Percutaneous cryoablation of tumours in solitary kidneys caused minimal morbidity and little change in serum creatinine levels. Although the follow-up is brief there was no local recurrence. Cryoablation may be a treatment option for patients with tumour in solitary kidneys but a long-term follow-up is needed to confirm these results.
OBJECTIVE: To investigate the use of cryoablation for small renal tumours (</= 5 cm) in patients with solitary kidneys, as the advantage of this technique might be to preserve nephrons for maintaining renal function with minimal morbidity. PATIENTS AND METHODS: Patients with a radiographically documented solid renal mass in a solitary kidney were evaluated for treatment with percutaneous cryoablation. Under general anaesthesia the patients were placed in an interventional magnetic resonance imaging (MRI) unit. A gradient imaging technique was used to locate the tumour and one to four 3-mm cryoprobes placed percutaneously into the tumour. An argon-based cryoablation system was used to treat the tumour with three freeze-thaw cycles, at a probe tip temperature of -120 degrees C. Patients were admitted for 23 h observation and assessed for follow-up at 1 week, 1, 3 and 6 months, and then every 6 months. Radiological imaging studies (computed tomography or MRI) were used at 1, 3 and 6 months and every 6 months afterward, to assess for recurrent or new tumour appearance. RESULTS: To date, 14 patients with renal masses in a solitary kidney have been treated; two were lost to follow-up and excluded from the analysis, leaving 10 men and two women (mean age 62.5 years, range 29-76). In all, 15 tumours (mean diameter 3.1 cm) were treated; the mean (range) treatment time was 96.7 (30-143) min. There were no complications during treatment. Two patients had gross haematuria afterward that resolved within 24 h. The mean follow-up was 17 (2-30) months, with three patients requiring re-treatment for incomplete tumour ablation. There is no radiographic evidence of local tumour recurrence to date. In two patients the tumour was not completely ablated. There was no significant change in serum creatinine from preoperative values. CONCLUSION: Percutaneous cryoablation of tumours in solitary kidneys caused minimal morbidity and little change in serum creatinine levels. Although the follow-up is brief there was no local recurrence. Cryoablation may be a treatment option for patients with tumour in solitary kidneys but a long-term follow-up is needed to confirm these results.
Authors: Young Hwii Ko; Hoon Choi; Sung Gu Kang; Hong Seok Park; Jeong Gu Lee; Je Jong Kim; Seok Ho Kang; Jun Cheon Journal: J Laparoendosc Adv Surg Tech A Date: 2010-05 Impact factor: 1.878
Authors: Archana Thakur; Peter Littrup; Elyse N Paul; Barbara Adam; Lance K Heilbrun; Lawrence G Lum Journal: J Immunother Date: 2011-06 Impact factor: 4.456
Authors: Manas R Gartia; Zhe Wu; Arun K De; Mao Ye; Santosh K Misra; Goutam Ghoshal; Corinne R Bromfield; Emery M Williams; Kuldeep Singh; Krishnarao V Tangella; Laurie Rund; Klaus Schulten; Lawrence B Schook; Partha S Ray; Everette C Burdette; Dipanjan Pan Journal: ACS Nano Date: 2015-10-12 Impact factor: 15.881
Authors: C Spreafico; N Nicolai; R Lanocita; C Morosi; M Catanzaro; E Civelli; T Torelli; S Stagni; L Piva; L F Frigerio; A Marchianò; R Salvioni Journal: Radiol Med Date: 2011-10-21 Impact factor: 3.469